Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
US11576895B2 · kind B2 · utility
4Cited by
38References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2017 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | Aug 31, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone (ABDNAZ), including formulations containing autologous whole blood and ABDNAZ that can be rapidly administered to a patient by intravenous infusion without any significant pain at the site of infusion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.